In the current study, BBR-treatment inhibited HNF4α mRNA and protein expression and reduced expression of miR122 and this was associated with reduction in gluconeogenesis and lipogenesis gene and protein expression in T2D mice and in PA-incubated HepG2 cells. Here, HNF4A is linked to type 2 diabetes mellitus.